|
|
|
Porcine circovirus type 2 infection is widespread. While essentially all U.S. pig herds are infected with PCV2, relatively few exhibit clinical signs of PCVAD. Since their introduction, PCV2 vaccines such as Suvaxyn® PCV2 One Dose have proven useful in controlling PCVAD.
To learn more about Suvaxyn PCV2 One Dose and the research supporting its use, download these materials.
These documents are in PDF (portable document format). PDF files require Adobe Acrobat Reader; click here to download this free program.
Suvaxyn PVC2 One Dose Information Brochure (PDF)
Learn why Suvaxyn PCV2 One Dose should be your first choice for reducing the effects of PCVAD.
Suvaxyn PCV2 One Dose Technical Reviews
Report on Safety Testing of Suvaxyn PCV2 One Dose (PDF)
This bulletin details the four studies conducted to assess the field safety of vaccinating commercial pigs with Suvaxyn PCV2 One Dose.
Report on the Immunogenicity of Suvaxyn PCV2 One Dose (PDF)
This bulletin discusses how vaccinating healthy, 4-week-old pigs with Suvaxyn PCV2 One Dose effectively prevented PCV2 viremia and reduced PCV2-associated lymphoid depletion compared to unvaccinated pigs.
Suvaxyn PCV2 One Dose Provides Protection in the Presence of Maternal Antibodies (PDF)
Because maternal antibodies can affect vaccine efficacy, vaccination timing is important. In the study reported here, vaccination with Suvaxyn PCV2 One Dose effectively induced active immunity, even when administered to pigs with moderate to high levels of passively acquired antibodies at vaccination.
Two Cross-Protection Studies Using Suvaxyn PCV2 One Dose (PDF)
In the first study summarized in this bulletin, vaccination with Suvaxyn PCV2 One Dose prevented development of mild/preclinical PMWS in pigs challenged with a "new" French pathogen strain 6 weeks after vaccination. In the second study, vaccinated pigs challenged with PCV2 4 months following vaccination had significantly reduced PCV2 viremia, histopathologic lesions and in situ hybridization staining.
The Unique Chimeric Formulation of Suvaxyn PCV2 One Dose (PDF)
This bulletin describes the chimeric vaccine virus featured in Suvaxyn PCV2 One Dose and explains the benefits it offers.
|
|
|
